The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  iShares Nasdaq Biotechnology Index Fund (IBB)     Sector: Financial  >  Industry: Misc. Financial Services
Investars YOU: New Site for Index Tracking and Investing

Jun 26, 2009 01:11 AM GMT
Mikerun
Return Risk
+1.04% MID
Principal

Below are 20 new stock indexes I have created, revised, and tracked over the past few years which are now featured at a new website called Investars YOU. The new site includes automated index tracking and allows investors to create custom stock portfolios based on their individual preferences.

<o:p>   </o:p>

http://biomedreports.com/articles/most-popular/1630-investars...

<o:p>   </o:p>

Cosmetic & Restorative Medicine Index

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Cosmetic and Restorative Medicine Index passively tracks the performance of companies that derive over 50% of revenue from any of the following activities: (1) prescription skin care therapeutics; (2) medical devices, products, services, OR equipment for procedures which are intended to enhance appearance; (3) medical devices, products, services, OR equipment for use as joint replacements, tissue repair agents, tissue reconstruction agents, surgical adhesives, and cardiovascular procedures; and (4) regenerative medicine products, services, and/or an active clinical pipeline which seeks to restore or repair the functionality of lost or damaged organ, tissue, cellular, and genetic material. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

BioMedReports.com Select Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The BioMedReports.com Select Index is an actively managed model portfolio of 30-40 stocks that will maintain at least a 90% sector weighting in healthcare with a focus on emerging small and micro-cap bio-pharmaceutical companies with market caps below $1 billion. Mid and large-cap stocks with market caps over $1 billion will typically account for about one-third to one-half of the index components. The selections will be made based on my research, experience, and activities as Managing editor of the website to identify companies which appear as either undervalued or those which are likely to benefit from upcoming binary event catalysts in the form of FDA decisions or key clinical trial results.

<o:p>   </o:p>

Cancer Dx/Tx Micro-Cap Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The passively managed Cancer Diagnostic & Therapeutic (Dx/Tx) Micro-Cap Index constituents reflect a cross-section of emerging cancer companies with market caps below $250 million at the inception date of 4/12/09, including (1) diagnostics (molecular diagnostics and device-based diagnostics), (2) lab services (personalized medicine applications to guide and track the effectiveness of cancer treatments), (3) drug discovery (screening and modifying compounds to achieve anti-cancer effects during the early stages of preclinical and Phase 1 clinical studies), (4) immunotherapy (a.k.a. cancer vaccines which are designed to stimulate the immune system to eradicate cancer), and (5) commercial or late-stage (Phase 2-3) clinical development. Components will only be removed from the index due to mergers, bankruptcies, or other corporate events that result in de-listing of the Company`s stock.

<o:p>   </o:p>

Emerging Diagnostics Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Emerging Diagnostics Index is passively managed and tracks the performance of companies with market caps below $250 million at the time of inclusion. The index includes diabetes monitoring device makers, laboratory services, clinical diagnostics, diagnostic imaging, diagnostic equipment makers, and molecular diagnostics. The index will only be updated to remove components which are no longer trading due to mergers, bankruptcies, or other corporate events that result in de-listing of the Company’s stock.

<o:p>   </o:p>

Global Airline Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Airline Index passively tracks the performance of companies with market caps over $200 million at the inception date of 7/16/08 which derive over 50% of revenue from passenger airline services. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Global Carbon Trading Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The passively managed Global Carbon Trading Index tracks the performance of companies which generate carbon credits through their business operations and/or are involved with the trading of carbon credits. Examples of these activities include the following: waste-to-energy, landfill or methane gas collection, financial exchanges for carbon credits, carbon credit investment firms, and renewable energy projects that result in the generation of carbon credits (e.g. hydro-power, farming, industrial). The index will only be updated to remove components which are no longer trading due to mergers, bankruptcies, or other corporate events that result in de-listing of the Company`s stock.

<o:p>   </o:p>

Global Generic Drug Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Generic Drug Index passively tracks the performance of companies which meet any of the following three requirements: (1) Derive either $500 million (USD) OR more than 50% of trailing 12-month revenues from the manufacture and sale of any type of generic (off-patent) prescription or over-the-counter (OTC) drug product intended for use by humans, including contract manufacturing services for drug products and biological agents; (2) Have one or more compound(s) in active clinical development OR have a pending ANDA with the FDA for a generic drug candidate; (3) As an alternative to the revenue requirement, companies may also qualify by receiving FDA approval for an abbreviated new drug application (ANDA) within the past 12 months. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Global Health IT Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Health Information Technology (Health IT) Index passively tracks the performance of companies with market caps below $10 billion that derive over either $50 million or 50% of their trailing 12-month revenue from products and services for the following activities: (1) electronic transmission, storage, and processing of prescriptions; (2) secure e-mail transmission for healthcare facilities; (3) electronic transmission, storage, and processing of medical imaging and diagnostic information; (4) electronic storage and systems for administrative functions of healthcare facilities and medical records; (5) electronic transmission, storage, and systems for healthcare market data and clinical trial data; (6) electronic systems, devices, and services for remote, real-time monitoring of patient health parameters; (7) medical transcription services, products, and systems for conversion into electronic medical records.

<o:p>   </o:p>

Global Metal Mining Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Metal Mining Index passively tracks the top-rated companies with market caps over $1 billion at the inception date of 7/22/08 that derive over 50% of revenue from the exploration, mining, extraction, processing, and sale of all types of precious metals, minerals, and industrial metals. The top rated companies are chosen based on their trailing 12-month stock price performance, market cap weighting, and net income weighting. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Global Railroad Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Railroad Index passively tracks the performance of companies that derive either more than 50% OR $100 million of trailing 12-month revenue from any of the following activities: (1) passenger or freight rail transport services; (2) railcar and locomotive leasing; (3) railcar and locomotive fleet management; (4) rail infrastructure, railcar, locomotive, and railcar/locomotive component parts manufacturing; (5) railcar, locomotive, and component parts repair or refurbishment. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Global Stem Cell Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Stem Cell Index is passively managed to track the performance of regenerative medicine companies (with stock prices of at least 15 cents at the time of inclusion) which derive over 50% of revenue or have compound(s) in active pre-clinical or clinical development which are designed to restore, replace, repair, or enhance the functionality or appearance of tissue and organ systems, including all types of embryonic and adult stem cell therapeutics. In addition, all types of products and services for stem cell banking are included in this index. The index will only be updated to remove components which are no longer trading due to mergers, bankruptcies, or other corporate events that result in de-listing of the Company’s stock.

<o:p>   </o:p>

Global Telecom Services Dividend Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Telecom Services Dividend Index passively tracks the performance of companies with market caps over $1 billion at the time of inclusion that meet the following requirements: (1) All such companies must derive at least 50% of their trailing 12-month revenue from any types of voice and data telecom services such as fixed line communications, wireless communications, and internet access provider services and (2) All such companies must have a trailing 12-month dividend yield of at least 1.5%. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Global Tobacco Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Tobacco Index tracks the performance of companies which derive over 50% of their revenue from the distribution or manufacturing of any type of tobacco product (e.g. cigarettes, cigars, chewing tobacco) or any related tobacco supplies (e.g. wrapping papers, tobacco leafs, filters). The index is passively managed with updates only as needed to reflect mergers, bankruptcies, and other corporate events which affect the component stocks.

<o:p>   </o:p>

Global Trucking & Logistics Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Global Trucking & Logistics Index passively tracks the performance of companies with market caps over $100 million at the time of inclusion that derive at least 50% of trailing 12-month revenue from any of the following activities: logistics and management support services for all types of transportation companies; all types of land-based, roadway freight forwarding freight transportation services; mail package delivery, transportation, and logistics services; and logistics management support services for roadway transportation companies. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Health Benefit Providers Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Health Benefit Providers Index is passively managed to track the performance of retail pharmacies, pharmacy benefit managers, managed care companies, health insurers, hospital pharmacy operators, workers compensation insurers, and specialty health benefit providers. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in the de-listing of the Company`s stock.

<o:p>   </o:p>

Highly Defensive Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Highly Defensive Index passively tracks the performance of 35 companies based in the Americas, Canada, and Europe with the largest market caps from the following industry groups: (A) Mass Merchant Discount Retailer (1); (B) Consumer Staples (11); (C) Telecom Services (3); (D) At-Home Services (2): Cable TV/Internet Provider (1), Internet Portal/Search Provider (1); (E) Electric Utilities – Domestic (U.S. based) (2); (F) Fast Food Restaurants (1); (G) Commodities (2): Gold Mining (1) Agri-Biotech (Seeds & Fertilizers) (1); (H) Healthcare (11); (I) Aerospace (Non-Commercial) & Defense (1); (J) Energy (1). Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Nation Cap Leaders Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Nation Cap Leaders Index passively tracks the performance of companies with market caps over $5 billion at the inception date of 8/11/08 which represent the market cap leaders from each nation, spanning developed, emerging, and frontier markets. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

NordiCaps Region Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The NordiCaps Region Index passively tracks the top-rated companies with market caps over $1 billion at the inception date of 7/21/08 that are based in the Nordic Region countries of Sweden, Denmark, Finland, Iceland, and Norway. The top rated companies are chosen based on their trailing 12-month stock price performance, market cap weighting, and revenue weighting. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Preventive Medicine Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Preventive Medicine Index passively tracks the performance of companies with market caps over $100 million at the time of inclusion that derive over either 50% or $100 million in trailing 12-month revenue from any of the following activities: (1) human vaccines which are already on the market or in active clinical development; (2) diagnostics and lab services; (3) diabetes care; and (4) vitamins, health supplements, functional foods, and weight loss products or services. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.

<o:p>   </o:p>

Regulatory Catalyst Index:

http://www.investinwhoyouare.com/iip_you_profiles.aspx?Portfo...

<o:p>   </o:p>

The Regulatory Catalyst Index tracks the performance of healthcare companies with pending new drug, biological agent, or medical device product decisions at the FDA. The index is actively managed and derived from the BioMedReports.com FDA Calendar database.


IBB:  This call was made on 06/26/09 @ $72.15
Rating:   Positive   $72.15 (06/26/09)
Closed:   09/07/2009 @ $78.99 (+9.48% in 73 days)


Comments (5)

Add Comment

Arrow_up
Arrow_down
orkun   N/A     1 point   commented 547 days ago reply

thanks..
sikiş
erotik video
porno
Ligtv Maç İzle
ansiklopedi
porno

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 415 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |

Arrow_up
Arrow_down
hiairjordan   N/A     1 point   commented 367 days ago reply

Air Jordan


Jordans


Jordan Shoes


Air Jordan 1


Air Jordan 2


Air Jordan 3


Air Jordan 4


Air Jordan 5


Air Jordan 6


Air Jordan 7


Air Jordan 8


Air Jordan 9


Air Jordan 10


Air Jordan 11


Air Jordan 12


Air Jordan 13


Air Jordan 14


Air Jordan 16


Air Jordan 17


Air Jordan 18


Air Jordan 19


Air Jordan 2009


Air Jordan 2010


Air Jordan XX3


Jordans Fusion



Jordan Fusion 1


Jordan Fusion 2


Jordan Fusion 3


Jordan Fusion 4


Jordan Fusion 5


Jordan Fusion 6


Jordan Fusion 9


Jordan Fusion 10


Jordan Fusion 11


Jordan Fusion 12



Jordans 6 Ring


Jordan Spizikes


Jordan 60+

Arrow_up
Arrow_down
baiyun   N/A     1 point   commented 354 days ago reply

pandora
pandora bracelet
bracelet pandora
beads pandora
pandora jewellery
pandora charms
pandora uk
pandora rings
pandora earrings
pandora bracelets
pandora jewellery
pandora beads
pandora bracelet
pandora charms uk
pandora charm
pandora online
cheap pandora charms
pandora bracelets uk
pandora jewellery uk
Watch replica
replica watch
replicas watches
watch replicas
swiss replica
swiss replica watch
Swiss replica watches
Fake watch
Fake watches

Arrow_up
Arrow_down
ink109   N/A     1 point   commented 346 days ago reply

Making the most of racist and anti-immigrant sentiments that were easy to exploit,” stock marketshe writes. The strategy worked perfectly, stock market todayand female midwives—mortgage calculatormany of them trained in Europe—mortgage calculatorfound themselves shunted aside by patients seeking the promise of scientific security.


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
iShares Nasdaq Biotechnology Index Fund (IBB)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
79.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated IBB
Positive +39.69% BioRunUp Mobile App Launches on iTunes, New Features Planned for Website
11/22/2010
9
Positive -0.43% BioRunUp / mikehavRx Merger: More Resources to Profit from FDA, Clinical Trial Binary Events
10/17/2010
9
Positive +11.85% Trading FDA, Clinical Trial Binary Events:$BPTH.OB $OREX $VRUS $ARNA
07/30/2010
9
Positive -0.62% Below is a summary of the new and improved premium features for subscribers at mikehavRx.com...
07/14/2010
9
Positive +2.41% Trading FDA, Clinical Trial Binary Events: BioRunUp.com Users Forum
07/12/2010
9
Positive -0.61% New Features Added for Trading FDA, Clinical Trial Binary Events: $ISA.TO $QCOR $DNDN $JAZZ
07/09/2010
9
Positive +4.07% Navigating the Markets: Transparency in Trading
07/07/2010
9
Positive -6.73% Trading FDA, Clinical Trial Binary Events at BioRunUp.com: $ISTA $ARNA $VVUS $ISA.TO
06/23/2010
8
Positive -2.66% Trading FDA, Clinical Trial Binary Events: Real Money Portfolio Tracking
06/20/2010
9
Positive +0.59% Trading FDA, Clinical Trial Binary Events: MarketGuru.com Site Closing
06/16/2010
9
Positive +2.02% Tracking FDA, Clinical Trial Binary Events and Healthcare Niche Indexes at mikehavRx.com
06/12/2010
9
Positive +1.22% FDA, Clinical Trial Stocks and Healthcare Niche Indexes Outpace Markets
06/05/2010
9
Positive +0.70% History of Success Trading FDA Catalyst Events: $CAMH, $AEN, $NVLT, $GTHP, $CTIC
06/01/2010
9
Positive -6.43% Near-Term FDA, Clinical Trial Extreme Trades: $ACCP.OB, $APPY, $AVNR, $BMOD.OB, $CYCC
05/16/2010
9
Positive +3.19% Personalized Stock Index Investing at Investars YOU
05/08/2010
9
Positive -9.51% mikehavRx.com Index Updates: Now Tracking Private Company FDA, Clinical Trial News
05/02/2010
9
Positive +0.48% Altoona Mirror Coverage of mikehavRx.com
04/26/2010
9
Positive +0.00% Event Calendar Tracking Added for mikehavRx.com Subscribers
04/23/2010
9
Positive -1.21% Trading FDA, Clinical Trial News vs. New Leveraged Biotech ETFs: $BIB $BIS
04/09/2010
9
Positive +0.46% HavRx Regulatory Catalyst Index up 80% since June 2009
03/19/2010
9
Positive +0.96% HavRx Stock Indexes: Updated Performance Stats
03/11/2010
9
Positive +2.66% mikehavRx.com Index Updates: Healthcare, Transports, and More
03/03/2010
9
Positive +3.69% Personalized HavRx Stock Index Investing with Investars YOU
02/22/2010
9
Positive +7.76% New Indexes to Track Healthcare Trends and More
09/07/2009
9
Positive +9.92% Lixte Biotech: Shifting Focus to Cancer Drug Discovery
04/03/2009
9
Positive +3.22% BioMedReports.com: Contributing Authors Wanted
03/16/2009
9
Positive -15.21% New Website for Healthcare Investors and Traders
02/06/2009
9
Positive +9.76% One Year Analysis of Healthcare ETFs
01/22/2009
9
Positive -3.72% ETF Innovators: 24 New Product Ideas
01/17/2009
9
Positive +1.20% Obama-Care Focused on Preventive Medicine
11/05/2008
9
Positive -1.72% Healthcare ETFs Outpace the Market
11/01/2008
9
Positive +4.65% Biogen Reports Another PML Case in Tysabri Patient
10/29/2008
9
Positive +7.08% Biotech Blues: Four Stocks on Sale with Hope
10/25/2008
9
Positive -6.60% An Earnings Encore for Amgen?
10/22/2008
9
Positive -9.80% Discovery Labs: The Next Biotech Winner?
10/06/2008
3
Positive +0.00% Updated FDA Calendar of Decision Dates
10/03/2008
3
Positive -6.95% Bristol-Myers Ups Bid to $62 for ImClone
09/23/2008
3
Positive -5.31% FDA Decision Date Calendar Through January 2009
09/21/2008
3
Positive -2.13% Discovery Labs: Poised for Eventful End of Year
09/18/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch